Despite innovative programs to increase colorectal cancer (CRC) screening amongst people >50 years of age, such the National Bowel Cancer Screening Program (NBCSP), current screening rates are low.
more
2018
Scholarship
|
2017
Scholarship
|
2017
Scholarship
|
2015
Scholarship
|
My interests are in statistical methods for the anlaysis of biomedical data. I'm particularly interested in:
In my current role at the statistical consultancy unit, I function more as a research facilitator, enabling the execution of methodologically rigorous and high-quality research. The extensive variety of projects keeps my work engaging and far from monotonous. Collaborations range from aiding basic science researchers in identifying genetic variants linked to specific diseases, to assisting public health researchers in designing and analyzing projects for state-wide implementation of school-based physical activity or diet programs. It's this broad spectrum of translational medical research, with its inherent diversity and potential for tangible impact, that initially drew me to the field of biostatistics.
A key aspect of my work centres around stressing the importance of thoughtful study design throughout the research process. I deeply resonate with Ronald Fisher's viewpoint that consulting a statistician after an experiment has concluded is akin to conducting a post-mortem. Instead, I advocate for the proactive engagement of statisticians early in the process. My ultimate goal is to foster meticulously designed studies that not only stand up to rigorous scrutiny but also yield profound, meaningful insights.
Chris Oldmeadow, as the Associate Director of Data Sciences at HMRI, spearheads a multidisciplinary team of biostatisticians, bioinformaticians, and health informaticians. They are bound by their common mission to empower clinicians and researchers in leveraging data for the enhancement of healthcare and patient outcomes.
As a pivotal member of the leadership team at HMRI, Chris has been instrumental in crafting and executing the institute's strategic vision. His approach is characterized by leading cross-functional teams and nurturing a culture that thrives on excellence and innovation.
With a keen eye on the technical aspects, Chris oversees the design, analysis, and data management of an array of intricate projects spanning diverse research fields such as cancer, stroke, cardiology, respiratory, public health, and health services.
Chris’s acumen as a statistician and data scientist makes him a sought-after collaborator. He holds esteemed positions on Scientific Advisory Boards and serves on independent data monitoring committees for large-scale clinical trials, offering his expertise to ensure the integrity and effectiveness of these studies.
Through his dedicated efforts, Chris persistently pushes the evolution of the data sciences landscape, reinforcing his commitment to enhancing the calibre of research at HMRI.
Laureate Professor Robert Sanson-Fisher, Dr Mariko Carey, Dr Elise Mansfield, Dr Chris Oldmeadow, Ms Natalie Dodd
Despite innovative programs to increase colorectal cancer (CRC) screening amongst people >50 years of age, such the National Bowel Cancer Screening Program (NBCSP), current screening rates are low.
moreLaureate Professor Robert Sanson-Fisher, Dr Mariko Carey, Dr Elise Mansfield, Dr Chris Oldmeadow, Ms Natalie Dodd
Despite innovative programs to increase colorectal cancer (CRC) screening amongst people >50 years of age, such the National Bowel Cancer Screening Program (NBCSP), current screening rates are low.
moreMs Natalie Dodd, L/Prof Rob Sanson-Fisher, Dr Mariko Carey, Dr Elise Mansfield, Dr Chris Oldmeadow
Improving uptake of colorectal cancer screening among primary care attendees
moreLaureate Professor Robert Sanson-Fisher, Dr Mariko Carey, Dr Elise Mansfield, Dr Chris Oldmeadow, Ms Natalie Dodd
Despite innovative programs to increase colorectal cancer (CRC) screening amongst people >50 years of age, such the National Bowel Cancer Screening Program (NBCSP), current screening rates are low.
more